[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:kaposi-sarcoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":110,"states":115},"Kaposi Sarcoma",16,14,[8,16,23,29,35,41,48,54,60,66,72,78,84,90,96,103],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07308886","Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)",[12],"Phase 2","RECRUITING","2026-08-26T02:17:16.980188Z","2026-07-05T05:32:16.676145Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT04303117","PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma",[20],"Phase 1\u002FPhase 2","2026-08-26T02:16:59.895916Z","2026-05-05T02:43:29.160286Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06445166","Propranolol for the Treatment of Kaposi Sarcoma in Adults",[12],"2026-08-26T02:18:39.640967Z","2026-05-05T02:43:29.044906Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT04305691","Trial of Ixazomib for Kaposi Sarcoma",[12],"2026-08-26T02:19:21.761002Z","2026-05-05T02:43:28.178229Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT04941274","Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma",[20],"2026-08-26T02:16:54.044282Z","2026-05-05T02:43:26.742813Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":46,"content_modified":47},"NCT04902443","Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV",[45],"Phase 1","2026-08-26T02:17:27.435233Z","2026-06-18T12:24:02.872345Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT05859074","A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer",[45],"2026-08-26T02:16:32.589113Z","2026-05-05T02:43:27.807952Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06751355","Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial",[],"2026-08-26T02:15:15.642947Z","2026-05-13T02:55:06.568449Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT06375122","Natural History Study of Kaposi Sarcoma",[],"2026-08-26T02:18:46.948970Z","2026-05-13T02:55:06.484860Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT04968288","Natural History of KSHV-Associated Multicentric Castleman s Disease",[],"2026-08-26T02:19:07.104270Z","2026-05-13T02:55:06.275783Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT05663502","Collecting Blood and Tissue Sample Donations for Research for HIV\u002FAIDS-Related Cancers",[],"2026-08-26T02:15:45.413021Z","2026-05-13T02:55:06.369655Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT03300830","Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease",[],"2026-08-26T02:19:08.862440Z","2026-05-13T02:55:06.121750Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT00842283","Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target",[],"2026-08-26T02:17:17.791881Z","2026-05-13T02:55:06.064828Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT00006518","Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer",[],"2026-08-26T02:17:21.315591Z","2026-05-13T02:55:06.028653Z",{"nct_id":97,"title":98,"phases":99,"status":100,"updated_at":101,"content_modified":102},"NCT07539454","Nirogacestat in Patients With Kaposi Sarcoma",[12],"NOT_YET_RECRUITING","2026-08-26T02:19:24.527214Z","2026-05-05T02:43:27.308500Z",{"nct_id":104,"title":105,"phases":106,"status":107,"updated_at":108,"content_modified":109},"NCT03993106","A Study of sEphB4-HSA in Kaposi Sarcoma",[12],"UNKNOWN","2026-08-03T01:58:27.073747Z","2026-05-05T02:43:27.604314Z",[111],{"biomarker":112,"count":113,"slug":114},"HIV Infection",4,"hiv-infection",[116,120,123,126,130],{"state":117,"count":118,"slug":119},"Maryland",10,"maryland",{"state":121,"count":113,"slug":122},"California","california",{"state":124,"count":113,"slug":125},"Missouri","missouri",{"state":127,"count":128,"slug":129},"Florida",3,"florida",{"state":131,"count":128,"slug":132},"New York","new-york"]